Inbrija (levodopa inhalation powder) — Medica

Initial criteria

• Patient is currently taking carbidopa-levodopa
• Patient is experiencing 'off' episodes (e.g., muscle stiffness, slow movements, or difficulty starting movements)
• Patient does not have asthma, chronic obstructive pulmonary disease, or other chronic underlying lung disease
• Inbrija is prescribed by or in consultation with a neurologist

Approval duration

1 year